Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Apostolos Tassiopoulos

Vascular Surgery Stony Brook, NY Medical Doctor

NPI 1073555884 CMS profile 229746

University Hospital, L5, Ste G, Stony Brook, NY 11794

Open in the dashboard

General payments

$246,462

557 records reported · program years 2019–2025

Research payments

$2,050

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$210,744 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Apostolos Tassiopoulos of Stony Brook, NY is reported in the CMS Open Payments database as having received $246,462 across 557 general payments and $2,050 in research payments paid to them. Separately, studies naming them as principal investigator received $210,744 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $51,376 97
2024 General $27,740 58
2023 General $33,640 86
2022 General $32,822 88
2021 General $23,493 62
2020 General $22,334 58
2020 Research $350 1
2019 General $55,057 108
2019 Research $1,700 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Apostolos Tassiopoulos
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Apostolos Tassiopoulos were reported at $51,376. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Apostolos Tassiopoulos Vascular Surgery median Middle half National median
2019 $55,057 $796 $226–$2,363 $163
2020 $22,334 $348 $118–$1,110 $114
2021 $23,493 $471 $158–$1,421 $132
2022 $32,822 $725 $222–$2,183 $149
2023 $33,640 $836 $257–$2,440 $160
2024 $27,740 $909 $252–$2,619 $164
2025 $51,376 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $124,839 194 payments
  2. Medtronic Vascular, Inc. $57,673 80 payments
  3. Bolton Medical Inc $35,365 85 payments
  4. Silk Road Medical, Inc. $15,993 36 payments
  5. W. L. Gore & Associates, Inc. $4,179 44 payments
  6. Terumo Medical Corporation $2,669 15 payments
  7. Boston Scientific Corporation $2,307 24 payments
  8. Cook Medical LLC $922 15 payments
  9. Penumbra, Inc. $482 14 payments
  10. Tactile Systems Technology Inc $436 11 payments
  11. Other $1,596 39 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $148,416 48 payments
  2. Consulting Fee $27,894 20 payments
  3. Travel and Lodging $25,544 64 payments
  4. Food and Beverage $24,888 412 payments
  5. Education $17,600 9 payments
  6. Honoraria $1,875 2 payments
  7. Grant $245 2 payments
Products named General payments · program years 2019–2025
  1. ENDURANT IIS $70,159 129 payments
  2. Endurant Aortic Stent Grafts $41,971 55 payments
  3. Heli-FX EndoAnchor System $19,506 22 payments
  4. Valiant Captivia $19,202 7 payments
  5. Endurant Aortic Stent Grafts $15,283 22 payments
  6. Grafts $12,840 14 payments
  7. Aptus Heli-FX $12,226 15 payments
  8. ENROUTE Transcarotid Stent $10,214 29 payments
  9. ENROUTE Transcarotid Neuroprotection System $10,214 29 payments
  10. Relay Plus $7,989 21 payments
  11. Other $60,499 296 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Cook Research Incorporated $2,050 3 payments

Billing to Medicare

Part B · data year 2024 · 83 billing codes

Paid by Medicare

$279,100

Medicare's payments for the services billed

Medicare patients

1,916

Average age 77

Services billed

3,191

928 women, 988 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 62%
Arthritis 56%
Diabetes 47%
Chronic kidney disease 44%
Heart failure 39%
Atrial fibrillation 38%
COPD 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
  • Janssen Pharmaceuticals, Inc $44
$44 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

560 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record